The presence of m1 to m5 receptors in human sclera: evidence of the sclera as a potential site of action for muscarinic receptor antagonists
- PMID: 16877267
- DOI: 10.1080/02713680600770609
The presence of m1 to m5 receptors in human sclera: evidence of the sclera as a potential site of action for muscarinic receptor antagonists
Abstract
Purpose: The aim of this study was to identify the presence of muscarinic acetylcholine receptors (mAChRs) in human sclera in order to determine whether the sclera is a potential site of action for mAChR antagonists.
Methods: Cell lines of human scleral fibroblasts were cultured in Dulbecco modified Ealge's medium. Reverse transcription-polymerase chain reaction (RT-PCR) and Northern blot analysis were used to detect mRNA expression of muscarinic acetylcholine receptors in the cell lines of the fibroblasts. Western blot analysis and immunocytochemistry were used to detect proteins of mAChRs in the cell lines. Immunohistochemical study was used to further detect the presence of mAChR proteins in the frozen scleral sections.
Results: The cultured fibroblasts demonstrated mRNA expression of five mAChRs (m1 to m5) in RT-PCR and Northern blot analysis. The molecular size of mRNA expression was largest for the m3 receptor, followed by the m2, m4, m5, and m1 in both RT-PCR and Northern blot analysis. Proteins of the m1 to m5 receptors were present in cell line fibroblasts under Western blot analysis and immunocytochemistry with a range of molecular weight from 80 kDa (m5) to 60 kDa (m1) in Western blot analysis. The presence of these five receptors was also detected in scleral tissues with immunohistochemistry.
Conclusions: This study demonstrated the presence of mAChR subtypes (m1 to m5) in human scleral fibroblasts at both mRNA and protein levels. This finding indicates that the sclera is a potential site of action for the currently used mAChR antagonists in prevention of human myopia.
Similar articles
-
[Expression of muscarinic acetylcholine receptor-1 in human scleral fibroblasts].Zhonghua Yan Ke Za Zhi. 2005 Nov;41(11):995-9. Zhonghua Yan Ke Za Zhi. 2005. PMID: 16318751 Chinese.
-
Changes in muscarinic acetylcholine receptor expression in form deprivation myopia in guinea pigs.Mol Vis. 2007 Jul 20;13:1234-44. Mol Vis. 2007. PMID: 17679952
-
Human skin fibroblasts express m2, m4, and m5 subtypes of muscarinic acetylcholine receptors.J Cell Biochem. 1999 Aug 1;74(2):264-77. J Cell Biochem. 1999. PMID: 10404395
-
Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function.Auton Autacoid Pharmacol. 2006 Jul;26(3):219-33. doi: 10.1111/j.1474-8673.2006.00368.x. Auton Autacoid Pharmacol. 2006. PMID: 16879488 Review.
-
New subtypes of muscarinic acetylcholine receptors.Trends Pharmacol Sci. 1989 Dec;Suppl:11-5. Trends Pharmacol Sci. 1989. PMID: 2694516 Review.
Cited by
-
Scleral HIF-1α is a prominent regulatory candidate for genetic and environmental interactions in human myopia pathogenesis.EBioMedicine. 2020 Jul;57:102878. doi: 10.1016/j.ebiom.2020.102878. Epub 2020 Jul 8. EBioMedicine. 2020. PMID: 32652319 Free PMC article.
-
Myopia: Mechanisms and Strategies to Slow Down Its Progression.J Ophthalmol. 2022 Jun 14;2022:1004977. doi: 10.1155/2022/1004977. eCollection 2022. J Ophthalmol. 2022. PMID: 35747583 Free PMC article. Review.
-
Distribution of adenosine receptors in human sclera fibroblasts.Mol Vis. 2008 Mar 14;14:523-9. Mol Vis. 2008. PMID: 18385786 Free PMC article.
-
Muscarinic signaling influences the patterning and phenotype of cholinergic amacrine cells in the developing chick retina.BMC Dev Biol. 2008 Feb 6;8:13. doi: 10.1186/1471-213X-8-13. BMC Dev Biol. 2008. PMID: 18254959 Free PMC article.
-
IMI Pathologic Myopia.Invest Ophthalmol Vis Sci. 2021 Apr 28;62(5):5. doi: 10.1167/iovs.62.5.5. Invest Ophthalmol Vis Sci. 2021. PMID: 33909033 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources